Anna DeFazio

41.5k citations
125 papers · 6.7k · 4 hit papers · h-index 36

Impact in

    • Ovarian cancer diagnosis and treatment
  • Oncology top 0.5%
    • PARP inhibition in cancer therapy
    • Cancer-related Molecular Pathways

Papers in

    • Cancer survivorship and care 10
    • Cancer-related Molecular Pathways 8
    • PARP inhibition in cancer therapy 6
    • HER2/EGFR in Cancer Research 4
    • Ovarian cancer diagnosis and treatment 39

Anna DeFazio

119 papers receiving 6.6k citations

Anna DeFazio's Hit Papers

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group 2012 · 868 citations
8680+11+22Years since publication2505007501000

Peers

Anna DeFazio
Comparison fields: 5 of 138
  • Reproductive Medicine 1.7k
  • Oncology 2.5k
  • Cancer Research 1.2k
  • Obstetrics and Gynecology 319
  • Genetics 1.0k
Replace Hani Gabra with:
Hani Gabra United Kingdom
Charles N. Landen United States
Robert Zeillinger Austria
Saundra S. Buys United States
Olaf Ortmann Germany
Charlie Gourley United Kingdom
Barbara C. Vanderhyden Canada
Martin Widschwendter United Kingdom
Johnathan M. Lancaster United States
Alain G. Zeimet Austria
Anna DeFazio relative to Hani Gabra United Kingdom Hani Gabra's profile →
Citations per field
00.5×1.5×
Hani Gabra · 1×
Citations per year

Countries citing papers authored by Anna DeFazio

Since Specialization
Citations

This map shows the geographic impact of Anna DeFazio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna DeFazio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna DeFazio more than expected).

Fields of papers citing papers by Anna DeFazio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna DeFazio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna DeFazio. The network helps show where Anna DeFazio may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna DeFazio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna DeFazio Line = papers co-authored together Anna DeFazio links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
Hit paper breakdown →
20081048
2
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
Hit paper breakdown →
2012868
3
Expression and amplification of cyclin genes in human breast cancer.
Hit paper breakdown →
1993583
4
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Hit paper breakdown →
2010523
5
Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2.
1994162
6 1995159
7 1987152
8
Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
2001145
9 2019142
10 2015132
11 2007119
12 2000115
13 2012109
14 1995109
15 2014107
16 201097
17 200892
18 200576
19 201675
20 200873

About Anna DeFazio

Anna DeFazio is a scholar working on Oncology, Reproductive Medicine, Molecular Biology, Genetics and Cancer Research, having authored 125 papers that have together received 6.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (39 papers), Cancer Genomics and Diagnostics (13 papers), Cancer survivorship and care (10 papers), Estrogen and related hormone effects (9 papers), BRCA gene mutations in cancer (9 papers), Cancer-related Molecular Pathways (8 papers), PARP inhibition in cancer therapy (6 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Reproductive Medicine (1.7k citations), Oncology (2.5k citations), Cancer Research (1.2k citations), Obstetrics and Gynecology (319 citations) and Genetics (1.0k citations). Anna DeFazio has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include David D.L. Bowtell, Sián Fereday, Penelope M. Webb, Joshy George, R. Sutherland, Stephen B. Fox, Yoke-Eng Chiew, Dariush Etemadmoghadam, C. K. W. Watts and Michael Friedländer. Their work appears in journals such as Gynecologic Oncology, Journal of Clinical Oncology, Clinical Cancer Research, International Journal of Cancer and International Journal of Gynecological Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact